A combination treatment has shown promise for treating a rare blood disease, according to a clinical trial published in the journal Blood.

Learn about why delayed hemolysis occurs, how it can affect newborns diagnosed with HDFN and how it can be treated.

Hematology tests for confirming hemolysis: Red cell osmotic fragility. Peripheral blood film. The treatment of an HTR must be guided by the clinical manifestations in the patient. The patient with ...

Learn more about the potential benefits of delayed umbilical cord clamping, including increased blood flow and improved iron ...

Heinz Bodies Intracellular inclusions usually attached to RBCs; composed of denatured hemoglobin Seen in hemoglobinopathies, RBC enzyme deficiencies, or after splenectomy Hemolysis Destruction of ...

Fulcrum Therapeutics' promising treatment for Sickle Cell Disease and their strong financial position, despite setbacks.

The direct antiglobulin test was positive for anti-C3d specificity, with cold agglutinin titer confirming the diagnosis of CAD.

Eculizumab biosimilar Elizaria demonstrates long-term safety and efficacy comparable with the reference product Soliris in ...

2022 — The destruction of red blood cells, or mechanical hemolysis, is an inevitable complication of interventional devices, so scientists want to gain a better understanding of the phenomenon.

Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment of patients with a ...